Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Accumulated Depreciation & Amortization (2016 - 2025)

Arcadia Biosciences' Accumulated Depreciation & Amortization history spans 12 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 1.77% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, up 1.77%, while the annual FY2025 figure was $1.9 million, 1.77% up from the prior year.
  • Accumulated Depreciation & Amortization reached $1.9 million in Q4 2025 per RKDA's latest filing, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.7 million in Q4 2021 to a low of -$612000.0 in Q1 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.1 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 112.24% in 2023, then soared 502.29% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $5.7 million in 2021, then plummeted by 50.33% to $2.8 million in 2022, then crashed by 30.91% to $1.9 million in 2023, then decreased by 3.91% to $1.9 million in 2024, then rose by 1.77% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Accumulated Depreciation & Amortization are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).